At a glance
- Note: These files are not yet 508.
- Slides will be added as they become available.
September 12, 2023
Welcome & Introductions
Introduction
Dr. G Lee
Dr. M Wharton
Coronavirus Disease 2019 (COVID-19) Vaccines
Dr. M Daley
Current landscape of SARS-CoV-2 lineages [12 pages]
Dr. N Thornburg
COVID-19 epidemiology [20 pages]
Dr. F Havers
Post-COVID conditions [16 pages]
Dr. S Saydah
COVID-19 vaccine effectiveness update [33 pages]
Dr. R Link-Gelles
Economic analysis of COVID-19 vaccination [45 pages]
Dr. L Prosser
COVID-19 vaccine safety surveillance [66 pages]
Dr. N Klein
Moderna 2023 – 2024 COVID-19 vaccine [16 pages]
Dr. F Priddy
Novavax 2023 – 2024 COVID-19 vaccine [10 pages]
Dr. F Dubovsky
Pfizer-BioNTech 2023 – 2024 COVID-19 vaccine [14 pages]
Dr. K Modjarrad
Evidence to Recommendations [150 pages]
Dr. M Wallace
Overview of COVID-19 vaccine implementation [18 pages]
Dr. G Peacock
Bridge Access Program [14 pages]
Dr. E Twentyman